Z-3084-2017 Class III Terminated

Recalled by Ameditech Inc — San Diego, CA

FDA device recall Z-3084-2017 was initiated by Ameditech Inc on Jun 26, 2017 and is designated Class III. Reason for recall: The kit box label incorrectly identifies PCP (instead of TCA) as one of the 10 drug analytes included in the kit. The pouch label, product insert, and the device itself are labeled correctly. The recall status is terminated (terminated Aug 6, 2019). Affected quantity: 263Kits.

Recall details

Product Type
Devices
Report Date
Sep 6, 2017
Initiation Date
Jun 26, 2017
Termination Date
Aug 6, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
263Kits

Product description

Alere iScreen Dx Urine Drug Screen Card, 20 Drug Detection, Kit Contents include 26 individually pouched devices and 1 IFU insert. The Alere iScreen Dx Drug Screen Card is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes monoclonal antibodies to selectively detect elevated levels of specific drugs in urine

Reason for recall

The kit box label incorrectly identifies PCP (instead of TCA) as one of the 10 drug analytes included in the kit. The pouch label, product insert, and the device itself are labeled correctly.

Distribution pattern

Nationwide Distribution to AZ, IL, IN, KY, NV, PA, TN, and TX

Code information

P/N IS10-DX; Lot No. U0731

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-3084-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-3084-2017. Report a data issue: hello@regdatalab.com.